Prognostication in Chronic Obstructive Pulmonary Disease: Implications for Lung Transplantation

Fernando J. Martinez; Robert Kotloff

doi:10.1055/s-2001-18421

Seminars in Respiratory and Critical Care Medicine, Inhaltsverzeichnis

Semin Respir Crit Care Med 2001; 22(5): 489-498
DOI: 10.1055/s-2001-18421

Prognostication in Chronic Obstructive Pulmonary Disease: Implications for Lung Transplantation

Fernando J. Martinez¹ , Robert Kotloff²

¹Division of Pulmonary and Critical Care Medicine, University of Michigan Medical Center, Ann Arbor, Michigan
²Division of Pulmonary and Critical Care Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

Abstract

ABSTRACT

Chronic obstructive pulmonary disease (COPD) is the most common disease for which single lung transplantation (SLT) is performed and is a frequent reason for bilateral lung transplantation (BLT). Recent data suggest a favorable survival advantage for patients with COPD undergoing lung transplantation compared with other diagnoses. This has led some investigators to question whether transplantation leads to improved survival in COPD patients compared with alternative treatment and whether this surgical therapy is appropriate in these individuals. These viewpoints may reflect the difficulties inherent in accurately predicting short- and long-term survival in patients with advanced COPD. Our review of the available data suggests that clinical, physiological, and radiographic features allow the identification of COPD patients with increased mortality despite maximal medical therapy. In these high risk individuals transplantation remains a viable therapeutic option.

KEYWORD

COPD - survival - lung transplantation

Volltext

Referenzen

REFERENCES

1 Hosenpud J D, Bennett L E, Keck B M, Boucek M M, Novick R J. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000. J Heart Lung Transplant . 2000; 19 909-931
2 Trulock E P. Lung transplantation. Am J Respir Crit Care Med . 1997; 152 947-952
3 Schulman L L. Lung transplantation for chronic obstructive pulmonary disease. Clin Chest Med . 2000; 21 849-865
4 Edelman J D, Kotloff R M. Lung transplantation: a disease-specific approach. Clin Chest Med . 1997; 18 627-644
5 Pochettino A, Kotloff R M, Rosengard B R. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease: intermediate-term results. Ann Thorac Surg . 2000; 70 1813-1819
6 Sundaresan R S, Shiraishi Y, Trulock E P. Single or bilateral lung transplantation for emphysema?. J Thoracic Cardiovas Surg . 1996; 112 1485-1495
7 D'Armini A M, Callegari G, Vitulo P. Risk factors for early death in patients awaiting heart-lung or lung transplantation. Transplantation . 1998; 66 123-127
8 DeMeester J, Smits J MA, Persijn G G. Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration. J Heart Lung Trans . 1999; 18 563-571
9 Hosenpud J D, Bennett L E, Keck B M. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet . 1998; 351 24-27
10 DeMeester J D, Smits J MA, Persijn G G. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant Experience. J Heart Lung Trans . 2001; 20 518-524
11 American Thoracic Society. International guidelines for the selection of lung transplant candidates. Am J Respir Crit Care Med . 1998; 158 335-339
12 Hodgkin J E. Prognosis in chronic obstructive pulmonary disease. Clin Chest Med . 1990; 11 555-569
13 Nishimura K, Tsukino M. Clinical course and prognosis of patients with chronic obstructive pulmonary disease. Curr Op Pulm Med . 2000; 6 127-132
14 Burrows B, Earle R H. Prediction of survival in patients with chronic airways obstruction. Am Rev Respir Dis . 1969; 99 865-871
15 Traver G A, Cline M G, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease: a 15-year follow-up study. Am Rev Respir Dis . 1979; 119 895-902
16 Anthonisen N R, Wright E C, Hodgkin J E. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis . 1986; 133 14-20
17 Anthonisen N R. Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials. Am Rev Respir Dis . 1989; 140(suppl) 95-99
18 Hansen E F, Pharaneth K, Laursen L C. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med . 1999; 159 1267-1271
19 Piccioni P, Caria E, Bignamini E. Predictors of survival in a group of patients with chronic airflow obstruction. J Clin Epidemiol . 1998; 51 547-555
20 Cooper C B, Waterhouse J, Howard P. Twelve-year clinical study of patients with hypoxic cor pulmonale given long-term domiciliary oxygen therapy. Thorax . 1987; 42 105-110
21 Diener C F, Burrows B. Further observations on the course and prognosis of chronic obstructive lung disease. Am Rev Respir Dis . 1975; 111 719-724
22 Postma D S, Burema J, Gimeno F. Prognosis in severe chronic obstructive pulmonary disease. Am Rev Respir Dis . 1979; 119 357-367
23 Postma D S, DeVries K, Koeter G H. Independent influence of reversibility of air-flow obstruction and non-specific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. Am Rev Respir Dis . 1979; 134 276-280
24 Postma D S, Gimeno F, van der Weele T L. Assessment of ventilatory variables in survival prediction of patients with chronic airflow obstruction: the importance of reversibility. Eur J Respir Dis . 1985; 67 360-368
25 Bates D V, Knott J MS, Christie R V. Respiratory function in emphysema in relation to prognosis. Q J Med . 1956; 25 137-157
26 Boushy S F, Thompson Jr K H, North L B. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis . 1973; 108 1373-1383
27 Kanner R E, Renzetti Jr D A, Stanish W M. Predictors of survival in subjects with chronic airflow limitation. Am J Med . 1983; 74 249-255
28 Chailleux E, Fauroux B, Binet G. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilatory: a 10-year analysis of ANTADIR observatory. Chest . 1996; 109 741-749
29 Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet . 1981; 1 681-686
30 Gorecka D, Gorzelak K, Sliwinski P. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxemia. Thorax . 1997; 52 674-679
31 Veale D, Chailleux E, Taytard A. Characteristics and survival of patients prescribed long-term oxygen therapy outside of prescription guidelines. Eur Respir J . 1998; 12 780-784
32 Foucher P, Baudouin N, Merati M. Relative survival analysis of 252 patients with COPD receiving long-term oxygen therapy. Chest . 1998; 113 1580-1587
33 Aida A, Miyamoto K, Nishimura M. Prognostic value of hypercapnia in patients with chronic respiratory failure during long-term oxygen therapy. Am J Respir Crit Care Med . 1998; 158 188-193
34 Connors Jr F A, Dawson N V, Thomas C. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med . 1996; 154 959-967
35 Costello R, Deegan P, Fitzpatrick M. Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med . 1997; 103 239-244
36 Saryal S, Celik G, Karabiyikoglu G. Distinctive features and long-term survival of reversible and chronic hypercapnic patients with COPD. Monaldi Arch Chest Dis . 1999; 54 212-216
37 Strom K. Oral corticosteroid treatment during long-term oxygen therapy in chronic obstructive pulmonary disease: a risk factor for hospitalization and mortality in women. Respir Med . 1998; 92 50-56
38 Petty T L, Bliss P L. Ambulatory oxygen therapy, exercise, and survival with advanced chronic obstructivce pulmonary disease (The Nocturnal Oxygen Therapy Trial revisited). Respir Care . 2000; 45 204-213
39 Gerardi D A, Lovett L, Benoit-Connors M L. Variables related to increased mortality following out-patient pulmonary rehabilitation. Eur Respir J . 1996; 9 431-435
40 Bowen J B, Votto J J, Thrall R S. Functional status and survival following pulmonary rehabilitation. Chest . 2000; 118 697-703
41 American Thoracic Society. Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med . 1995; 152(suppl) 77-120
42 Flaherty K R, Kazerooni E A, Martinez F J. Differential diagnosis of chronic airflow obstruction. J Asthma . 2000; 37 201-223
43 Gelb A F, Zamel N, Hogg J C. Pseudophysiologic emphysema resulting from severe small-airways disease. Am J Respir Crit Care Med . 1998; 158 815-819
44 Burrows B, Bloom J W, Traver G A. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med . 1987; 317 1309-1314
45 Kazerooni E A. Radiologic evaluation of emphysema for lung volume reduction surgery. Clin Chest Med . 1999; 20 845-861
46 Keistinen T, Tuuponen T, Kivela S L. Survival experience of the population needing hospital treatment for asthma or COPD at age 50-54. Respir Med . 1998; 92 568-572
47 Vestbo J, Prescott E, Lange P. Vital prognosis after hospitalization for COPD: a study of a random population sample. Respir Med . 1998; 92 772-776
48 Wu M, Eriksson S. Lung function, smoking and survival in severe alpha₁-antitrypsin deficiency, PiZZ. J Clin Epidemiol . 1988; 41 1157-1165
49 Seersholm N, Dirksen A, Kok-Jensen A. Airways obstruction and two-year survival in patients with severe alpha1-antitrypsin deficiency. Eur Respir J . 1994; 7 1985-1987
50 Seersholm N, Kok-Jensen A. Survival in relation to lung function and smoking cessation in patients with severe hereditary alpha₁-antitrypsin deficiency. Am J Respir Crit Care Med . 1995; 151 369-373
51 The Alpha-1 Antitrypsin Deficiency Registry Study Group. Survival and FEV1 decline in individuals with severe deficiency of α₁-antitrypsin. Am J Respir Crit Care Med . 1998; 158 49-59
52 Miyamoto K, Aida A, Nishimura M. Gender effect on prognosis of patients receiving long-term home oxygen therapy. Am J Respir Crit Care Med . 1995; 152 972-976
53 Incalzi R A, Fuso L, DeRosa M. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J . 1997; 10 2794-2800
54 Leibowitz D W, Caputo A L, Shapiro G C. Coronary angiography in smokers undergoing evaluation for lung transplantation: is routine use justified?. J Heart Lung Trans . 1994; 33 701-703
55 Incalzi R A, Fuso L, De Rosa M. Electrocardiographic signs of chronic cor pulmonale: a negative prognostic finding in chronic obstructive pulmonary disease. Circulation . 1999; 99 1600-1605
56 Oswald-Mammosser M, Weitzenblum E, Quoix E. Prognostic factors in COPD patients receiving long-term oxygen therapy: importance of pulmonary artery pressure. Chest . 1995; 107 1193-1198
57 Skwarsky K, MacNee W, Wraith P K. Predictors of survival in patients with chronic obstructive pulmonary disease treated with long-term oxygen therapy. Chest . 1991; 100 1522-1527
58 Keller A, Ragaz A, Borer P. Predictors of early mortality in patients with long-term oxygen home therapy. Respiration . 1985; 48 216-221
59 Wurternberger G, Zielinski J, Sliwinksy P. Survival in chronic obstructive pulmonary disease after diagnosis of pulmonary hypertension related to long-term oxygen therapy. Lung . 1990; 168(suppl) 762-769
60 Gray-Donald K, Gibbons L, Shapiro S H. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med . 1996; 153 961-966
61 Schols A W J M, Slangen J, Volovics L. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med . 1998; 157 1791-1797
62 Landbo C, Prescott E, Lange P. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med . 1999; 160 1856-1861
63 Madill J, Gutierrez C, Grossman J. Nutritional assessment of the lung transplant patient: body mass index as a predictor of 90-day mortality following transplantation. J Heart Lung Trans . 2001; 20 288-296
64 Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease: a clinical trial. Ann Intern Med . 1980; 93 391-398
65 Dubois P, Machiels J, Smeets F. CO transfer capacity as a determining factor of survival for severe hypoxaemic COPD patients under long-term oxygen therapy. Eur Respir J . 1990; 3 1042-1047
66 Clini E, Sturani C, Porta R. Outcome of COPD patients performing nocturnal non-invasive mechanical ventilation. Resp Med . 1998; 92 1215-1222
67 Chaouat A, Weitzenblum E, Kessler R. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J . 1999; 14 1002-1008
68 Hjalmarsen A, Melbye H, Wilsgaard T. Prognosis for chronic obstructive pulmonary disease patients who receive long-term oxygen therapy. Int J Tuberc Lung Dis . 1999; 3 1120-1126